Literature DB >> 15541883

Gamma-secretase subunit composition and distribution in the presenilin wild-type and mutant mouse brain.

R Siman1, S Salidas.   

Abstract

Studies conducted in cell culture indicate that the gamma-secretase involved in amyloid beta-formation and Notch signaling is a multisubunit aspartic protease. Little is known, however, of the structure, function, or localization of gamma-secretase in the adult brain, or possible effects of familial Alzheimer's disease (FAD)-causing mutations on the brain protease. We report here that mouse brain contains a complex composed of gamma-secretase subunits presenilin-1 N-terminal fragment, presenilin-1 C-terminal fragment, Nicastrin, Aph-1a and Pen-2. A homozygous FAD-linked Presenilin-1 knock-in mutation does not alter relative subunit levels. Immunocytochemical localization of gamma-secretase subunits revealed overlapping but distinct regional and subcellular distributions. All subunits are expressed throughout the neuraxis predominantly in neurons, and are present in axons. Their distributions and levels of expression are unaffected by mutant presenilin-1. In a presenilin-1/amyloid precursor protein double knock-in mouse, subunits are associated with plaques, but are expressed at similar levels in amyloid-rich and -poor regions. gamma-Secretase subunits are distributed much more extensively than circumscribed amyloid deposits, suggesting the importance of other factors for localized amyloid deposition. These results indicate a widespread neuronal function for gamma-secretase in the adult brain, and suggest the pathogenic mechanism of FAD-linked mutations does not involve alterations in the composition, expression or brain distribution of the protease. The subcellular localization of gamma-secretase subunits is consistent with a nerve terminal source for amyloid aggregates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15541883     DOI: 10.1016/j.neuroscience.2004.08.028

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

1.  Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann-Pick type C1-deficient mouse brains.

Authors:  A Kodam; M Maulik; K Peake; A Amritraj; K S Vetrivel; G Thinakaran; J E Vance; S Kar
Journal:  Glia       Date:  2010-08-15       Impact factor: 7.452

2.  Amyloid deposition and advanced age fails to induce Alzheimer's type progression in a double knock-in mouse model.

Authors:  Gauri H Malthankar-Phatak; Yin-Guo Lin; Nicholas Giovannone; Robert Siman
Journal:  Aging Dis       Date:  2011-07-28       Impact factor: 6.745

3.  Cellular distribution of gamma-secretase subunit nicastrin in the developing and adult rat brains.

Authors:  A Kodam; K S Vetrivel; G Thinakaran; S Kar
Journal:  Neurobiol Aging       Date:  2007-01-12       Impact factor: 4.673

4.  Insulin-Like Growth Factor-1 Alleviates Expression of Aβ1-40 and α-, β-, and γ-Secretases in the Cortex and Hippocampus of APP/PS1 Double Transgenic Mice.

Authors:  Fangfang Song; Tingting Liu; Songyan Meng; Fengqing Li; Yina Zhang; Lihong Jiang
Journal:  J Mol Neurosci       Date:  2018-11-09       Impact factor: 3.444

5.  Combination therapy prevents amyloid-dependent and -independent structural changes.

Authors:  Gauri Malthankar-Phatak; Shane Poplawski; Nikhil Toraskar; Robert Siman
Journal:  Neurobiol Aging       Date:  2011-01-22       Impact factor: 4.673

6.  Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease.

Authors:  Chen Zhang; Elizabeth McNeil; Lindsay Dressler; Robert Siman
Journal:  Exp Neurol       Date:  2006-10-27       Impact factor: 5.330

Review 7.  Application and implementation of selective tissue microdissection and proteomic profiling in neurological disease.

Authors:  Jay Jagannathan; Jie Li; Nicholas Szerlip; Alexander O Vortmeyer; Russell R Lonser; Edward H Oldfield; Zhengping Zhuang
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

Review 8.  The use of mouse models to understand and improve cognitive deficits in Down syndrome.

Authors:  Ishita Das; Roger H Reeves
Journal:  Dis Model Mech       Date:  2011-08-04       Impact factor: 5.758

9.  Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease.

Authors:  Scott J Webster; Adam D Bachstetter; Linda J Van Eldik
Journal:  Alzheimers Res Ther       Date:  2013-05-24       Impact factor: 6.982

10.  The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy.

Authors:  Robert Siman; Ryan Cocca; Yina Dong
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.